Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Autor:
Zihang Xu, Wanyi Ng, Chen Fang, Chenyuan Gong, Shiguo Zhu, Lixin Wang, Guifan Si, Xuewei Yan, Chao Yao, Xiaowen Zhu
Publikováno v:
Pharmaceutical Biology
article-version (VoR) Version of Record
Pharmaceutical Biology, Vol 59, Iss 1, Pp 47-53 (2021)
article-version (VoR) Version of Record
Pharmaceutical Biology, Vol 59, Iss 1, Pp 47-53 (2021)
Context Therapeutic benefits of immunotherapy are restricted by cancer immune-resistance mechanisms. Rediocide-A (Red-A), a natural product extracted from Traditional Chinese Medicine, is a promising agent to battle against cancer which acts as an im
Autor:
Liuhua Chen, Shirong Cai, Chuangqi Chen, Wu Song, Jinning Ye, Yulong He, Yujie Yuan, Jidong Zuo, Jianjun Peng
Publikováno v:
Cancer Biology & Therapy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction The hyperthermic intraperitoneal chemotherapy (HIPEC) has been widely applied in clinical practice for peritoneal carcinomatosis (PC). The temperature is one of the important elements affecting the efficacy of HIPEC, and it can become fl
Autor:
Torben Hansen, Jan Lindebjerg, John Pløen, Anders Jakobsen, Lise Nottelmann, Eva Fernebro, Lene Byriel, Lars Henrik Jensen, Rikke F. Andersen
Publikováno v:
Jensen, L H, Andersen, R F, Byriel, L, Fernebro, E, Jakobsen, A, Lindebjerg, J, Nottelmann, L, Ploen, J & Hansen, T F 2020, ' Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers ', Acta oncologica (Stockholm, Sweden), vol. 59, no. 3, pp. 298-301 . https://doi.org/10.1080/0284186X.2019.1701201
Background: Molecular markers may identify subgroups of patients with clinically distinct behavior and response to treatment. In some gastrointestinal tumors, KRAS has prognostic value and negative predictive value. This is the first prospective stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3de678a70b042a92af30048dc421aea
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 651-659 (2020)
Purpose To determine the effectiveness of ablation for pulmonary metastases (PM) from hepatocellular carcinoma (HCC). Methods Between 2010 and 2017, the study analyzed 39 patients who had a median age of 59 years. Primary HCC was under control and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ba31a204722c721c631d67d1724adb
Autor:
Marco Tucci, Gabriele Madonna, Luigia Stefania Stucci, Francesco Mannavola, M. Capone, Paolo A. Ascierto, Francesco Silvestris, Anna Passarelli, Patrizia Lopalco
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Immunotherapy is effective in metastatic melanoma (MM) but most studies failed in discovering a biomarker predictive of clinical response. Exosomes (Exo) from melanoma cells are detectable in sera of MM patients similarly to those produced by immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d866cc3b0145d4d01fff8d55d06c939
https://europepmc.org/articles/PMC5749659/
https://europepmc.org/articles/PMC5749659/